INIS
hepatomas
100%
ornithine
100%
aminotransferases
100%
inactivation
44%
tumors
22%
growth inhibition
22%
cancer
11%
drugs
11%
clinical trials
11%
origin
11%
mortality
11%
kinases
11%
inhibition
11%
statistics
11%
tyrosine
11%
monoclonal antibodies
11%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Ornithine Oxoacid Aminotransferase
100%
Cancer Inhibition
22%
Monoclonal Antibody
11%
Protein Tyrosine Kinase Inhibitor
11%
4 Aminobutyric Acid
11%
Catenin
11%
Cancer Mortality
11%
Drug
11%
Chemistry
Ornithine
100%
Growth Inhibition
22%
Potential
22%
% Inhibition
11%
Monoclonals
11%
Mechanistic Study
11%
Preclinical Study
11%
Clinical Trial
11%
Gamma-Aminobutyric Acid
11%